P-105 * Pembrolizumab (MK-3475) for patients with recurrent...

P-105 * Pembrolizumab (MK-3475) for patients with recurrent or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma: The phase 2 KEYNOTE-059 study

Fuchs, C., Denker, A., Tabernero, J., Van Cutsem, E., Ohtsu, A., Lam, B., Koshiji, M., Bang, Y.- J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.105
Date:
June, 2015
File:
PDF, 36 KB
2015
Conversion to is in progress
Conversion to is failed